Price
196.09
-1.82%52W Range
Market Cap
₹946.87 Cr
Traded: ₹1.50 Cr (0.16%) 0.0x
Free Float: ₹477.60 Cr (0.31% of FF traded)
Volume · 60D trend
75.83 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +9.0% | +7.0% | +7.0% | -- | +12.0% | Stable |
| ROE | +11.0% | +9.0% | +8.0% | -- | -- | Decelerating |
| Return | +14.0% | -4.0% | +0.0% | +14.0% | -- | Accelerating |
| Profit | +8.0% | -16.0% | -2.0% | -- | -28.0% | Stable |
Quarterly Results
Mar 2023
Dec 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 154 | 234 | 194 | 118 | 135 | 172 | 166 | 152 | 139 | 186 | 159 | 153 | 117 | 149 | 158 |
| Expenses | 138 | 201 | 177 | 123 | 121 | 155 | 146 | 137 | 121 | 164 | 135 | 130 | 111 | 137 | 146 |
| Operating Profit | 16 | 33 | 18 | -5 | 14 | 17 | 20 | 15 | 18 | 22 | 24 | 23 | 6 | 12 | 12 |
| OPM % | 10.3% | 14.1% | 9.1% | -4.5% | 10.4% | 9.9% | 11.9% | 9.7% | 13.0% | 11.7% | 14.8% | 15.0% | 5.4% | 8.0% | 7.8% |
| Other Income | 2 | 0 | 0 | 0 | 3 | 3 | 0 | 1 | 3 | 10 | 2 | 0 | 2 | 4 | 2 |
| Interest | 3 | 3 | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 6 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 |
| Profit Before Tax | 9 | 25 | 11 | -12 | 10 | 14 | 14 | 10 | 15 | 25 | 21 | 18 | 4 | 11 | 9 |
| Tax % | 23.8% | 25.6% | 13.0% | -14.6% | 24.7% | 29.4% | 25.0% | 23.4% | 24.7% | 26.0% | 23.0% | 24.6% | 23.0% | 26.0% | 24.0% |
| Net Profit | 7 | 19 | 9 | -10 | 7 | 10 | 10 | 7 | 11 | 19 | 16 | 14 | 3 | 8 | 7 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 1.4 | 3.9 | 1.9 | -2.1 | 1.5 | 2.0 | 2.2 | 1.5 | 2.3 | 3.9 | 3.3 | 2.9 | 0.6 | 1.7 | 1.4 |
| Sales Growth (YoY) | 13.9% | 35.8% | 16.9% | -22.2% | -3.0% | -7.4% | 4.6% | -0.7% | 19.2% | 24.9% | 0.6% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -34.2% | 20.5% | 64.8% | -12.8% | -21.6% | 3.7% | 9.7% | 8.7% | -25.1% | 17.1% | 4.2% | 30.4% | -21.5% | -5.7% | -- |
| OP Growth (YoY) | 11.9% | 92.7% | -10.5% | -135.8% | -22.2% | -21.2% | -15.8% | -35.5% | 187.8% | 80.8% | 91.4% | -- | -- | -- | -- |
| OP Growth (QoQ) | -52.0% | 85.5% | 436.4% | -137.4% | -17.3% | -13.9% | 34.8% | -18.9% | -16.3% | -8.0% | 3.3% | 261.8% | -47.4% | -2.6% | -- |
| Profit Growth (YoY) | -- | 95.0% | -10.0% | -234.0% | -33.0% | -48.0% | -34.0% | -46.0% | 301.0% | 132.0% | 127.0% | 196.0% | -64.0% | -54.0% | -65.4% |
| EPS Growth (YoY) | -9.7% | 94.5% | -10.2% | -234.6% | -33.0% | -47.9% | -34.1% | -46.5% | 303.5% | 131.1% | 127.8% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -64.5% | 101.5% | 194.2% | -233.8% | -23.4% | -6.9% | 41.2% | -33.5% | -40.4% | 17.7% | 14.7% | 401.8% | -65.9% | 16.0% | -- |
| OP Margin | 10.3% | 14.1% | 9.1% | -4.5% | 10.4% | 9.9% | 11.9% | 9.7% | 13.0% | 11.7% | 14.8% | 15.0% | 5.4% | 8.1% | 7.8% |
| Net Margin | 4.3% | 8.1% | 4.8% | -8.4% | 5.5% | 5.6% | 6.3% | 4.9% | 8.0% | 10.0% | 9.9% | 9.0% | 2.4% | 5.4% | 4.4% |
| Material Cost % | -- | 63.0% | 67.0% | 64.0% | 63.0% | 67.0% | 64.0% | 64.0% | 62.0% | 69.0% | 63.0% | 62.0% | 69.0% | 66.0% | 70.0% |
| Employee Cost % | -- | 7.0% | 9.0% | 14.0% | 11.0% | 10.0% | 9.0% | 10.0% | 10.0% | 7.0% | 9.0% | 9.0% | 11.0% | 10.0% | 8.0% |
| P/S | 1.35 | 1.35 | 1.29 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 37.86 | 35.77 | 48.16 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.79 | 1.74 | 1.59 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Proceedings of AGM, Voting results and Scrutinzer report
Result Q1 FY 2026-27
Unaudited Standalone and Consolidated Result for the quarter ended June 30, 2026
For Q1 FY 2026-27
Unaudited Standalone and Consolidated Result for the Quarter Ended June 30, 2026
Annual report 2026
Kopran Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Results for the Q1 FY 2026-27
Record Date for Payment of Dividend
for the Quarter 1 FY 2026-27
Appointment of Mr. Vijay L Thange as Chief Technical Officer (CTO) of the Company.
Closure of Trading Window for Q1 FY 2026-27
Outcome of NCLT convened meeting for equity shareholders, secured creditor and unsecured creditor held on 03.06.2026
Annual Secretarial Compliance Report for the year ended March 31, 2026
Newspaper Advertisement for the Q4 Results FY 2025-26
Investor presentation for 2026.
Standalone and Consolidated Audited Financial result for the Fourth quarter and Year ended on March 31, 2026.
Appointment of Director & Issue of shares in Subsidiary company Kopran Research laboratories ltd
Notice of shareholders meeting convened by NCLT to be held on June 03,2026
Kopran Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve Standalone and Consolidated Audited ....
Newspaper Advertisement pursuant to NCLT Order dated April 09, 2026 Mumbai Bench, for Notice served to the members, creditors, for the approval of Scheme of Amalgamation.
Notice convening the Meeting of Equity Shareholders, Secured and Unsecured Creditors of Transferee and Transferor Company pursuant to NCLT order dated April 09, 2026.
Pronouncement of NCLT order dated April 09, 2026 for Scheme of Amalgamation.
Clarification on Price Movement
The Exchange has sought clarification from Kopran Ltd on April 9, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended March 31, 2026.
Company reply to BSE surveillance letter on volume movement
The Exchange has sought clarification from Kopran Ltd on April 8, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited.
Closure of trading window
Resignation of Non Executive Non- Independent Director Mr. Adarsh Somani (DIN:00192609)
Observation letter from NSE
Observation Letter with no adverse observations from Bombay Stock Exchange of India (BSE Limited) on Scheme of Amalgamation Received.
Cyber-attack at Khopoli Factory
Investor Presentation for Q3 FY 2025-26
Newspaper Advertisement for the Q3 Results FY 2025-26
Unaudited Results for standalone and consolidated for Q3 FY 2025-26
Disclosure under Regulation 30 SEBI (LODR) 2015 -Inspection /search by GST Authorities
Kopran Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated ....
for the Quarter ended December 31, 2025
CRISIL has Reaffirmed the Credit Rating till March 31, 2026
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kumkum Somani & Others
Results for the third quarter ended December 31, 2025
Results for the Quarter ended September 30, 2025
Investor Presentation for Financial Year Q2 2025-26 Result
Investor Presentation on Q2 FY 2025-26 results
Results for the Quarter ended September 30, 2025
Kopran Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve unaudited Standalone and Consolidated ....
Compliance Certificate for the Quarter ended September 30,2025
For Quarter ended September 30,2025
Retirement of Director(s)
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kumkum Somani & PACs
Annual Reports
15Credit Ratings
6Concalls
20Jan 2026
31 Jan 2026Nov 2025
30 Nov 2025Nov 2025
30 Nov 2025Jul 2025
31 Jul 2025May 2025
31 May 2025Mar 2025
31 Mar 2025Feb 2025
28 Feb 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024Aug 2024
31 Aug 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023May 2022
31 May 2022Nov 2021
30 Nov 2021Jun 2021
30 Jun 2021Feb 2021
28 Feb 2021Nov 2020
30 Nov 2020Held by ETFs
1 ETFs hold kopran · sorted by weight
Held by Mutual Funds
1 schemes hold kopran · sorted by weight